Study S001110

A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of HRS9531 Injection in Chinese Adolescents With Obesity

ClinicalTrials.gov record

Registration

Registration: NCT07559136
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 48
Start: 2026-06-12
Primary completion: 2027-02
Lead sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions: Overweight and Obesity
Interventions: DRUG:HRS9531 injection；Placebo
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Adverse Events (AEs) [up to Week 28]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.